Integrated BioPharma, Inc. (OTCMKTS:INBP – Get Free Report) shares traded down 2.2% on Wednesday . The stock traded as low as $0.20 and last traded at $0.22. 32,550 shares were traded during trading, an increase of 241% from the average session volume of 9,557 shares. The stock had previously closed at $0.23.
Integrated BioPharma Trading Down 2.2 %
The stock has a fifty day moving average of $0.20 and a 200-day moving average of $0.21.
Integrated BioPharma Company Profile
Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.
Featured Articles
- Five stocks we like better than Integrated BioPharma
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- How Much Can You Make in Stocks in One Month?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- This Is the Top Large-Cap Stock Insiders Are Buying
- Overbought Stocks Explained: Should You Trade Them?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Integrated BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
